| General Information |
| Organism |
Mus musculus, mouse |
| Cell Line Description |
NIT-1 is an immortalized pancreatic β-cell line established in 1990 by Edward H. Leiter and colleagues at The Jackson Laboratory. This cell line was derived from a transgenic non-obese diabetic (NOD) mouse carrying the SV40 large T antigen under the control of the rat insulin promoter (RIP). NIT-1 cells grow as an adherent monolayer and exhibit an epithelioid morphology, frequently forming loose aggregates or clusters. Globally, NIT-1 is recognized as an indispensable model for Type 1 diabetes (T1D) research in the fields of endocrinology, metabolism, and autoimmunity. Derived from the NOD mouse strain—a primary animal model for autoimmune diabetes—NIT-1 cells naturally express β-cell autoantigens (such as insulin and GAD65), making them a vital tool for studying autoimmune-mediated β-cell destruction, cytokine toxicity, and the mechanisms of insulin secretion. |
| Tissue |
Pancreas; derived from pancreatic islet cells (Beta cells) |
| Cell Type |
Pancreatic Beta Cell |
| Strain |
NOD/Lt (Non-Obese Diabetic) |
| Disease |
Normal / Transgenic Autoimmune Beta-Cell Model (RIP-Tag1) |
| Morphology |
Epithelial-like; grows as adherent clusters |
| Gender |
Female |
| Age |
Adult transgenic mouse (10 to 12 weeks old) |
| Product Format |
Frozen |
| Growth Mode |
Adherent (tends to form multi-layered aggregates) |
| Biosafety Level |
1 or 2 (Depends on regional institutional guidelines regarding integrated SV40 T-antigen viral sequences) |
| Applications |
1. Directly simulate the pathogenesis of autoimmune-mediated β-cell destruction, insulitis, and type 1 diabetes in vitro; 2. Evaluate the cytotoxic effects of cytotoxic T lymphocytes (CTLs) and the key targets of apoptosis mediated by pro-inflammatory cytokines (such as TNF-α, IL-1β, and IFN-γ); 3. Elucidate the pathways of insulin biosynthesis, processing, and glucose-stimulated insulin secretion (GSIS); 4. Screen for novel anti-diabetic compounds, β-cell protective agents, and immunomodulatory drugs; 5. Establish syngeneic or allogeneic β-cell transplantation models using NOD mouse strains. |
| Shipped In |
Dry ice |
| Storage Temperature |
−196°C |
| Characteristics |
| Tumorigenic |
Yes; forms insulinomas when engrafted into syngeneic or immunocompromised host mice. |
| Transformant |
Simian virus 40 (SV40) large T-antigen driven by the rat insulin promoter (RIP-Tag1). |
| Secretory Profile |
Natively produces and secretes intact insulin and proinsulin. The cells respond to glucose and secretagogues (e.g., glibenclamide, IBMX) with elevated insulin release, though glucose responsiveness may attenuate over extended passaging. |
| Ultrastructure |
Electron microscopy confirms the presence of classic beta-cell secretory granules with dense crystalline cores surrounded by a clear halo. |
| Growth Kinetics |
Slow to moderate adherent expansion; population doubling time spans approximately 36 to 48 hours. |
| Mycoplasma Test |
Negative |
| Culture Conditions and Handling |
| Subculturing |
1. Remove and discard the spent complete culture medium from the culture vessel. 2. Gently rinse the cell monolayer with sterile PBS (without Ca2+ and Mg2+) to remove residual serum containing trypsin inhibitors. 3. Add 1.0 to 2.5 mL of 0.25% trypsin-0.53 mM (0.02%) EDTA solution, pre-warmed to the appropriate temperature, to cover the cell layer. 4. Incubate at 37°C for 3 to 7 minutes, monitoring closely under an inverted microscope. Gently tapping the culture flask helps detach cell clumps. 5. Add an equal volume of pre-warmed complete growth medium to immediately neutralize trypsin activity. 6. Gently pipette the cell suspension up and down to dissociate cell clumps into a single-cell suspension; then centrifuge at approximately 125 × g for 5 minutes, aspirate the supernatant, resuspend the cells in fresh growth medium, and distribute them into new culture vessels. |
| Thawing Protocol Note |
NIT-1 cells are sensitive to pH changes during early post-thaw recovery. Prior to introducing the thawed vial contents, place the culture vessel containing fresh complete growth medium into the 5% CO2 incubator for at least 15 minutes to allow the medium to equilibrate to its normal physiological pH range (7.0 to 7.6). |
| Medium Renewal |
Every 2 to 3 days |
| Subcultivation Ratio |
Passage cultures at 70%–80% confluence at a standard split ratio of 1:2 to 1:4. Maintain a seeding density of at least 3.0 X 10^4 to 5.0 X 10^4 cells/cm2. |
| Culture Conditions |
Atmosphere: Air, 95%; CO2, 5%; Temperature: 37°C |
| Cryopreservation |
90% Complete culture growth medium + 10% DMSO |